HoyleCohen’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$4.87M Sell
5,380
-62
-1% -$49.6K 0.37% 70
2024
Q1
$4.23M Sell
5,442
-75
-1% -$53.4K 0.32% 78
2023
Q4
$3.22M Buy
5,517
+99
+2% +$57.8K 0.26% 90
2023
Q3
$2.91M Sell
5,418
-77
-1% -$39.7K 0.27% 87
2023
Q2
$2.58M Sell
5,495
-338
-6% -$142K 0.23% 93
2023
Q1
$2M Buy
5,833
+14
+0.2% +$4.72K 0.19% 111
2022
Q4
$2.13M Sell
5,819
-70
-1% -$24.8K 0.21% 100
2022
Q3
$1.9M Buy
5,889
+5
+0.1% +$1.58K 0.21% 100
2022
Q2
$1.91M Sell
5,884
-99
-2% -$29.7K 0.2% 103
2022
Q1
$1.71M Buy
5,983
+211
+4% +$54.3K 0.15% 117
2021
Q4
$1.59M Buy
5,772
+110
+2% +$27.9K 0.13% 122
2021
Q3
$1.31M Sell
5,662
-440
-7% -$109K 0.12% 122
2021
Q2
$1.4K Sell
6,102
-20
-0.3% -$4.02K 0.11% 122
2021
Q1
$1.14M Buy
6,122
+219
+4% +$42.8K 0.12% 130
2020
Q4
$997K Sell
5,903
-515
-8% -$76.9K 0.12% 123
2020
Q3
$950K Buy
6,418
+27
+0.4% +$4.18K 0.14% 107
2020
Q2
$1.05M Hold
6,391
0.18% 98
2020
Q1
$887K Sell
6,391
-60
-0.9% -$8.24K 0.18% 100
2019
Q4
$848K Buy
6,451
+41
+0.6% +$4.75K 0.13% 113
2019
Q3
$717K Buy
6,410
+50
+0.8% +$5.57K 0.12% 123
2019
Q2
$705K Hold
6,360
0.12% 120
2019
Q1
$825K Hold
6,360
0.15% 114
2018
Q4
$736K Buy
6,360
+274
+5% +$30.6K 0.15% 105
2018
Q3
$653K Buy
6,086
+86
+1% +$8.6K 0.12% 112
2018
Q2
$512K Buy
+6,000
New +$493K 0.1% 123

Other funds holding LLY

HoyleCohen's LLY Position: Q2 2024 in Review

HoyleCohen reduced its Eli Lilly (LLY) stake by 1.1% in Q2 2024, selling an estimated $49.6K and leaving 5,380 shares worth $4.87M. The position accounts for 0.37% of the portfolio, ranked #70.

HoyleCohen first reported a position in LLY in Q2 2018 and has held it in 25 quarters since. 3,564 funds tracked by Wall St. Rank hold LLY as of Q2 2024.

  • HoyleCohen held 5,380 shares of Eli Lilly worth $4.87M as of Q2 2024.
  • HoyleCohen sold 62 Eli Lilly shares in Q2 2024, an estimated $49.6K.
  • Eli Lilly made up 0.37% of HoyleCohen's portfolio in Q2 2024, its #70 holding.
  • HoyleCohen first reported a position in Eli Lilly in Q2 2018 and has held it in 25 quarters since.
  • 3,564 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2024.

Based on HoyleCohen's 13F filing for Q2 2024, filed 19 Jul 2024.